نتایج جستجو برای: transmission blocking vaccine

تعداد نتایج: 397418  

2011
Anna L. Goodman Andrew M. Blagborough Sumi Biswas Yimin Wu Adrian V. Hill Robert E. Sinden Simon J. Draper

The ookinete surface protein Pfs25 is a macrogamete-to-ookinete/ookinete stage antigen of Plasmodium falciparum, capable of exerting high-level anti-malarial transmission-blocking activity following immunization with recombinant protein-in-adjuvant formulations. Here, this antigen was expressed in recombinant chimpanzee adenovirus 63 (ChAd63), human adenovirus serotype 5 (AdHu5) and modified va...

Journal: :Saudi medical journal 2006
Khaled S Tabbara

Leishmaniasis is a vector-born protozoan disease. Approximately 12 million individuals are affected worldwide with an estimated annual incidence of 1.5-2 million. Two clinical manifestations are recognized, cutaneous, and visceral, both of which are common in the Middle East. In both forms, infection is chronic, with potential deformities, persistence following cure, and lifelong risk of reacti...

2016
Kawsar R. Talaat Ruth D. Ellis Janet Hurd Autumn Hentrich Erin Gabriel Noreen A. Hynes Kelly M. Rausch Daming Zhu Olga Muratova Raul Herrera Charles Anderson David Jones Joan Aebig Sarah Brockley Nicholas J. MacDonald Xiaowei Wang Michael P. Fay Sara A. Healy Anna P. Durbin David L. Narum Yimin Wu Patrick E. Duffy

Transmission-blocking vaccines (TBVs) that target sexual stage parasite development could be an integral part of measures for malaria elimination. Pfs25 is a leading TBV candidate, and previous studies conducted in animals demonstrated an improvement of its functional immunogenicity after conjugation to EPA, a recombinant, detoxified ExoProtein A from Pseudomonas aeruginosa. In this report, we ...

Journal: :hepatitis monthly 0
marina sena lopes da silva sacchetto department of pathology and clinical dentistry (dpco), federal university of piaui, teresina, brazil; federal university of piaui, teresina, brazil. tel: +86-99070207, fax: +86-32225461 simone souza lobão veras barros department of pathology and clinical dentistry (dpco), federal university of piaui, teresina, brazil thaís de alencar araripe department of pathology and clinical dentistry (dpco), federal university of piaui, teresina, brazil aryvelto miranda silva department of pathology and clinical dentistry (dpco), federal university of piaui, teresina, brazil symonara karina medeiros faustino department of pharmacy, differential integral faculty (facid), teresina, brazil josé mário nunes da silva department of science and health, federal university of piaui, teresina, brazil

conclusions dental academics were unsure about the means of infection and prevention against hbv. many of them had not completed the immunization scheme and did not have the test of seroconversion. the serological analysis revealed unprotection, even after students completed the vaccination schedule. results of the 179 students surveyed, 58.1% knew about the degree of virulence of the hepatitis...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2006
Yimin Wu Craig Przysiecki Elizabeth Flanagan Sheila N Bello-Irizarry Roxana Ionescu Olga Muratova Gelu Dobrescu Lynn Lambert David Keister Yvette Rippeon Carole A Long Li Shi Michael Caulfield Alan Shaw Allan Saul John Shiver Louis H Miller

The development of protein subunit vaccines to combat some of the world's deadliest pathogens such as a malaria parasite, Plasmodium falciparum, is stalled, due in part to the inability to induce and sustain high-titer antibody responses. Here, we show the induction of persistent, high-titer antibody responses to recombinant Pfs25H, a human malarial transmission-blocking protein vaccine candida...

2018
Neeraj Kapoor Ivana Vanjak James Rozzelle Aym Berges Wei Chan Gang Yin Cuong Tran Aaron K Sato Alexander R Steiner Thao P Pham Ashley J Birkett Carole A Long Jeff Fairman Kazutoyo Miura

Malaria, one of the most common vector borne human diseases, is a major world health issue. In 2015 alone, more than 200 million people were infected with malaria, out of which, 429 000 died. Even though artemisinin-based combination therapies (ACT) are highly effective at treating malaria infections, novel efforts toward development of vaccines to prevent transmission are still needed. Pfs25, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید